‘I’m an ER Doctor—This Common Cold Remedy Sends People to the Hospital Every Year'

An ER doctor reveals that using decongestants for cold symptoms carries risks that land people in the hospital each year. "Two big reasons decongestants send people to the hospital each year include ...

Evoke Pharma Rallies After QOL Agrees to Buy Company for $11/Share

QOL agreed to buy Evoke for $11 a share in a deal expected to close by the end of the year. QOL said it will fund the transaction with cash on hand. Shares of Evoke have more than doubled to $10.70 ...
Medscape

‘Weed’ Whackers: Biologic Agents Reshaping Nasal Polyp Care

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...

Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical

QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in CashRepresents a 139.7% premium to most recent ...